ARCHIVES

Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics

This article is from The Cancer Letter archive.

Vol. 40 No. 01 | January 3, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Budget: How Did NCI Spend Last Year’s Increase? Klausner Lists Activities

November 19, 1999

Schmidt’s Doubts Threaten Control Saturation Program

August 22, 1975

NCI Moves Slowly, Carcinogenesis CANCERGRAMS For May, June Missing

June 1, 1984

Funding Opportunities.

March 15, 2002

Cancer Advocates Use Benefit Analysis To Press For Funds

May 11, 1990

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997